Viritis is a biotech company pioneering a next-generation antisense-based platform for rapid development of antiviral drugs. Our novel technology targets all strains of a given virus, offering a scalable and precise solution for current and emerging viral threats.
Our platform combines AI-driven algorithms with patented molecule design to bind specifically to viral RNA. Once attached, it activates the cell’s innate defense mechanisms, degrading the virus from within— without harming the host. After completing its function, the molecule naturally disintegrates within hours, leaving no harmful residues.
In POC studies, our platform demonstrated 97.1% cellular protection against the target virus. Its innovative structure also makes it highly stable, can be lyophilize, and easy to store and transport—ideal for global deployment.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Israel, Il
- Industry
- Biotechnology
- Keywords
- Drug Discovery & Development, Antiviral Therapeutics, Therapeutic Innovation, Life Sciences Startups.
- HQ
- Israel
Viritis Ltd Questions
Viritis Ltd's LinkedIn profile is https://il.linkedin.com/company/viritis
Viritis Ltd has
4 employees.
View email and phone details for 4
employees at Viritis Ltd.
Viritis Ltd's industry is
Biotechnology
Viritis Ltd's top competitors are
Road2,
Bilieye,
Phenofast,
Polyfos 3d,
Entera Bio Ltd.,
Rosalind Bioculture,
Ionflux-Nrg,
Meter Robotics,
Firewave,
Xarcam.
Viritis Ltd's categories are Biotechnology
Viritis Ltd's founding year is 2022
